U.S. medical device company Royal Oak Medical Devices has been testing its so-called rep-less sales model. Now it's to be rolled out across the country.
Available in Europe since 2010, IlluminOss will soon be seeing commencement of US studies into its novel photodynamic bone stabilization system.
A retrospective data analysis from a study into St. Jude's CardioMEMS™ HF monitoring sensor shows significant a reduction in 30-day hospital readmission rates for patients age 65 and older.
Cardica, Inc. is to pull the remainder of the latest iteration of its MicroCutter XCHANGE 30® from sale, drawing a line under the device until a next generation version is ready.
OrthoGrid® Systems, Inc. has announced the release of HipGrid™ for anterior and posterior approach THR.
Imagine a device that can instantly tell you from a serum, urine, saliva or blood sample whether you have a particular infectious disease? Sounds implausible but the prototype is ready for clinical trial early next year.
Covidien's acquisition of Sapheon this summer is looking like a smart move as pivotal clinical study results at 6 months suggest it successfully treats symptomatic varicose veins.
Baxano had better find a buyer pretty soon because the news that it has now filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code suggests it's running out of runway.
Boston Scientific reports that its SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent System met its primary endpoint in the first successful U.S. pivotal trial of a bioabsorbable polymer stent.
FDA clears new device for use along with a standard colonoscope to improve visibility in areas behind folds in colon wall.
Orthopedics This Week has awarded ZipLine Medical's clever skin closure device its "Best Technology in Spine Care" Award for 2014.
sam claims to be the first device in a new technology category of ultrasound bio-electronics.
New data point to the clinical and economic value of Medtronic's cardiac resynchronization therapy devices for the treatment of heart failure.
Essential Medical reports on the initial First in Man studies for its revolutionary MANTA Large Bore Vascular Closure device, which is designed to seal 18F large bore femoral punctures.
We're getting properly fixated on the power of social media in healthcare, especially medtech marketing. Can we therefore steal ideas from the powerhouse retailers?